Evidence map›Paper›PMID 38127939›Full record

ArticlePloS one2023

Bar press durations as a reliable and robust measure of frustration-related operant behavior: Sensitivity to incentive downshift and dose-response paradigms.

Yorkiris Mármol Contreras, Tileena E S Vasquez, Poonam Shah, Kelsey Payne, Jessica Di Re, Fernanda Laezza, Thomas A Green

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Frustrative Nonreward: Behavior, Circuits, Neurochemistry, and Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yorkiris Mármol ContrerasDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID 0000-0002-8887-7303
Tileena E S VasquezDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States of America.
Poonam ShahDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States of America.
Kelsey PayneDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States of America.
Jessica Di ReDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States of America.
Fernanda LaezzaDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States of America.
Thomas A GreenDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID 0000-0002-6726-1200

Funding

Translational Explorations in Substance Use DisordersT32DA007287 · NIDA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Kathryn A. Cunningham, Jonathan Dean Hommel · 1994 to 2026
$4.7M
Neurotrophin-dependent regulation of voltage-gated sodium channelsR01MH124351 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2020 to 2024
$3.0M
Neurotoxicology of deltamethrin in the developing brainR01ES031823 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GREEN, THOMAS ARTHUR, LAEZZA, FERNANDA · 2020 to 2024
$2.8M
Retinoic acid signaling: a novel factor for addiction-related behaviorR01DA047102 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GREEN, THOMAS ARTHUR, LAEZZA, FERNANDA · 2018 to 2022
$2.2M
Discovery of Chemical Probes for Psychiatric Disorders and AddictionR01MH111107 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA, ZHOU, JIA · 2016 to 2018
$1.6M
Brain derived extracellular vesicles-mediated neurotoxicity of deltamethrinR21ES034956 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA, PENDYALA, GURUDUTT · 2023 to 2023
$423k
NIDA NIH HHS R01 DA047102NIDA NIH HHS T32 DA007287NIEHS NIH HHS R01 ES031823NIEHS NIH HHS R21 ES034956NIMH NIH HHS R01 MH111107NIMH NIH HHS R01 MH124351
6 · The paper itself

Abstract

In humans, frustrating experiences are known to trigger relapse events and individuals with higher frustration intolerance show increased risk of developing substance use disorders (SUDs). Despite this clear relationship, frustration-related behavior is seldom studied concurrently with self-administration behavior in rodent models. A major obstacle has been the lack of robust, quantitative assays of frustration-related operant behavior thus far. In previous work, we identified increased bar press (BP) durations in response to frustrating conditions in rats self-administering natural or drug rewards. Here, to propose BP durations as a measure of frustration-related behavior, we conducted an operant successive negative contrast (oSNC) study and found that increases in BP durations are observed in the absence of increased effort, providing evidence that this is a psychological phenomenon. Moreover, we assess the viability of widespread use of BP duration measurements as a behavioral tool by quantifying performance as it pertains to sensitivity, robustness, replicability, and sex differences. We conclude that increases in BP durations are a highly sensitive psychological response to frustrating conditions and that this measure is robust, replicable, and applicable to both sexes.

Indexed as

FrustrationMotivationAnimalsConditioning, OperantFemaleHumansMaleRatsReward

Identifiers

PMID38127939
PMCPMC10734988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.